Work

Induction with Bortezomib and Dexamethasone (BD) Followed By Risk Adapted High Dose Melphalan and Autologous Stem Cell Transplantation and BD Consolidation in Patients with AL Amyloidosis: A Phase II Feasibility Study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.3178.3178

Authors: Heather Landau, Nicole Montanez, Alexandra Cowan, Hoover Elizabeth, Carlos Flombaum, Jennifer Liu, Mat Maurer, Nikoletta Lendvai, Ola Landgren, Sergio A. Giralt, Hani Hassoun

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, NewYork–Presbyterian Hospital, Cornell University

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551462243

FWCI: 0.145

Cites:

Cited by: 1

Related to: 10